Cargando…

Morphological and Microstructural Changes of the Hippocampus in Early MCI: A Study Utilizing the Alzheimer's Disease Neuroimaging Initiative Database

BACKGROUND AND PURPOSE: With the aim of facilitating the early detection of Alzheimer's disease, the Alzheimer's Disease Neuroimaging Initiative proposed two stages based on the memory performance: early mild cognitive impairment (EMCI) and late mild cognitive impairment (LMCI). The curren...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Peter, Ryoo, Hojin, Park, Jinah, Jeong, Yong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Neurological Association 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5392456/ https://www.ncbi.nlm.nih.gov/pubmed/28176504 http://dx.doi.org/10.3988/jcn.2017.13.2.144

Ejemplares similares

Cognitive variability—A marker for incident MCI and AD: An analysis for the Alzheimer's Disease Neuroimaging Initiative
por: Anderson, Eric D., et al.
Publicado: (2016)

Classification of early-MCI patients from healthy controls using evolutionary optimization of graph measures of resting-state fMRI, for the Alzheimer’s disease neuroimaging initiative
por: Zamani, Jafar, et al.
Publicado: (2022)

Clusters of male and female Alzheimer’s disease patients in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) database
por: Gamberger, Dragan, et al.
Publicado: (2016)

The prevalence and biomarkers’ characteristic of rapidly progressive Alzheimer's disease from the Alzheimer's Disease Neuroimaging Initiative database
por: Ba, Maowen, et al.
Publicado: (2017)

Alzheimer disease biomarkers may aid in the prognosis of MCI cases initially reverted to normal
por: Vermunt, Lisa, et al.
Publicado: (2019)

The use of back propagation neural networks and (18)F-Florbetapir PET for early detection of Alzheimer’s disease using Alzheimer’s Disease Neuroimaging Initiative database
por: Ozsahin, Ilker, et al.
Publicado: (2019)

Using the Alzheimer's Disease Neuroimaging Initiative to improve early detection, diagnosis, and treatment of Alzheimer's disease
por: Veitch, Dallas P., et al.
Publicado: (2021)

Q & A: The Alzheimer's disease neuroimaging initiative
por: Aisen, Paul S
Publicado: (2011)

Microstructural Neurodegeneration of the Entorhinal-Hippocampus Pathway along the Alzheimer’s Disease Continuum
por: Uchida, Yuto, et al.
Publicado: (2023)

Detection of early Alzheimer's disease in MCI patients by the combination of MMSE and an episodic memory test
por: Pozueta, Ana, et al.
Publicado: (2011)

Six psychotropics for pre-symptomatic & early Alzheimer's (MCI), Parkinson's, and Huntington's disease modification
por: Lauterbach, Edward C.
Publicado: (2016)

Direction of Information Flow in Alzheimer's Disease and MCI Patients
por: Vecchio, Fabrizio, et al.
Publicado: (2011)

Identification of Early-Stage Alzheimer's Disease Using Sulcal Morphology and Other Common Neuroimaging Indices
por: Cai, Kunpeng, et al.
Publicado: (2017)

Neuropsychological comparison of incident MCI and prevalent MCI
por: Hansen, Allison, et al.
Publicado: (2018)

Episodic Memory in Amnestic Mild Cognitive Impairment (aMCI) and Alzheimer’s Disease Dementia (ADD): Using the “Doors and People” Tool to Differentiate between Early aMCI—Late aMCI—Mild ADD Diagnostic Groups
por: Chatzikostopoulos, Athanasios, et al.
Publicado: (2022)

Key inflammatory pathway activations in the MCI stage of Alzheimer’s disease
por: Pillai, Jagan A., et al.
Publicado: (2019)

Biomarker-Based Signature of Alzheimer’s Disease in Pre-MCI Individuals
por: Chipi, Elena, et al.
Publicado: (2019)

PET Neuroimaging of Alzheimer's Disease: Radiotracers and Their Utility in Clinical Research
por: Bao, Weiqi, et al.
Publicado: (2021)

Hyperplanar Morphological Clustering of a Hippocampus by Using Volumetric Computerized Tomography in Early Alzheimer’s Disease
por: Suksuphew, Sarawut, et al.
Publicado: (2017)

Executive Dysfunction in MCI: Subtype or Early Symptom
por: Reinvang, Ivar, et al.
Publicado: (2012)

Identification of prognostic factors to predict cognitive decline of patients with early Alzheimer's disease in the Japanese Alzheimer's Disease Neuroimaging Initiative study
por: Yagi, Takuya, et al.
Publicado: (2019)

Integrative EEG biomarkers predict progression to Alzheimer's disease at the MCI stage
por: Poil, Simon-Shlomo, et al.
Publicado: (2013)

Metabolic correlates of reserve and resilience in MCI due to Alzheimer's Disease (AD)
por: Bauckneht, Matteo, et al.
Publicado: (2018)

Hyperactivation of monocytes and macrophages in MCI patients contributes to the progression of Alzheimer's disease
por: Munawara, Usma, et al.
Publicado: (2021)

FOOD AND SUPPLEMENT COMBINATIONS TO PREVENT OR POSTPONE AGING, MCI, AND ALZHEIMER’S DISEASE
por: Pruchnicki, Alec, et al.
Publicado: (2022)

Lanabecestat: Neuroimaging results in early symptomatic Alzheimer's disease
por: Zimmer, Jennifer A., et al.
Publicado: (2021)

How random is the random forest? Random forest algorithm on the service of structural imaging biomarkers for Alzheimer's disease: from Alzheimer's disease neuroimaging initiative (ADNI) database
por: Dimitriadis, Stavros I., et al.
Publicado: (2018)

Clinical and cognitive characteristics of preclinical Alzheimer's disease in the Japanese Alzheimer's Disease Neuroimaging Initiative cohort
por: Ihara, Ryoko, et al.
Publicado: (2018)

Biomarkers and phenotypic expression in Alzheimer’s disease: exploring the contribution of frailty in the Alzheimer’s Disease Neuroimaging Initiative
por: Canevelli, Marco, et al.
Publicado: (2020)

Effectiveness of regional DTI measures in distinguishing Alzheimer's disease, MCI, and normal aging()
por: Nir, Talia M., et al.
Publicado: (2013)

EEG oscillations during word processing predict MCI conversion to Alzheimer's disease
por: Mazaheri, Ali, et al.
Publicado: (2017)

An Intelligent System for Early Recognition of Alzheimer’s Disease Using Neuroimaging
por: Odusami, Modupe, et al.
Publicado: (2022)

Neuroimaging in Alzheimer's Disease for Early Diagnosis: A Comprehensive Review
por: Aramadaka, Saikumar, et al.
Publicado: (2023)

Mapping longitudinal scientific progress, collaboration and impact of the Alzheimer’s disease neuroimaging initiative
por: Yao, Xiaohui, et al.
Publicado: (2017)

Generation and quality control of lipidomics data for the alzheimer’s disease neuroimaging initiative cohort
por: Barupal, Dinesh Kumar, et al.
Publicado: (2018)

The Worldwide Alzheimer's Disease Neuroimaging Initiative: ADNI‐3 updates and global perspectives
por: Weber, Christopher J., et al.
Publicado: (2021)

The Metadata Coverage Index (MCI): A standardized metric for quantifying database metadata richness
por: Liolios, Konstantinos, et al.
Publicado: (2012)

Neuroimaging basis in the conversion of aMCI patients with APOE-ε4 to AD: study protocol of a prospective diagnostic trial
por: Chen, Guan-Qun, et al.
Publicado: (2016)

Resilience in Mild Cognitive Impairment (MCI): Examining the Level and the Associations of Resilience with Subjective Wellbeing and Negative Affect in Early and Late-Stage MCI
por: Tsormpatzoudi, Styliani Olympia, et al.
Publicado: (2023)

Microstructural Neuroimaging of Frailty in Cognitively Normal Older Adults
por: Tian, Qu, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8kpgdipvmcugl6ckn9nm2n1e2b